Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea
· Delayed Price · Currency is KRW 13,730
-720 (-4.98%)
Mar 9, 2026, 3:30 PM KST
KRX:271980 Market Cap
KRX:271980 has a market cap or net worth of 200.07 billion as of March 9, 2026. Its market cap has increased by 20.02% in one year.
Market Cap
200.07B
Enterprise Value
276.10B
Revenue
621.98B
Ranking
n/a
PE Ratio
10.19
Stock Price
13,730.00
Market Cap Chart
Since March 15, 2022, KRX:271980's market cap has decreased from 390.14B to 200.07B, a decrease of -48.72%. That is a compound annual growth rate of -15.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 210.56B | -4.62% |
| Dec 30, 2025 | 220.76B | 32.89% |
| Dec 30, 2024 | 166.12B | -33.33% |
| Dec 28, 2023 | 249.17B | -18.65% |
| Dec 29, 2022 | 306.28B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pharmaceutical | 212.04B |
| JW Lifescience | 200.22B |
| Samjin Pharmaceuticals | 222.85B |
| Samil Pharmaceutical Co.,Ltd | 223.34B |
| AptaBio Therapeutics | 193.84B |
| Daewon Pharmaceutical | 229.34B |
| REYON Pharmaceutical | 191.66B |
| Chong Kun Dang Holdings | 233.27B |